REQUEST A DEMO
Total
USD $0.00
Search more companies

Drogueria Inti S.A. (Bolivia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Drogueria Inti S.A. Profile Updated: August 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Drogueria Inti S.A is a company that operates in the pharmaceutical industry of Bolivia. Currently, it’s the biggest and most important player in the sector. Its mission is to protect people’s health by producing different types of medicines. Inti got awarded a Good Manufacturing Practices certificate by the Ministry of Health and Sport of Bolivia.

Headquarters
Calle Lucas Jaimes N 1959
La Paz; La Paz;

Contact Details: Purchase the Drogueria Inti S.A. report to view the information.

Website: http://www.inti.com.bo

Basic Information
Total Employees:
Purchase the Drogueria Inti S.A. report to view the information.
Registered Capital:
Purchase the Drogueria Inti S.A. report to view the information.
Financial Auditors:
Purchase the Drogueria Inti S.A. report to view the information.
Incorporation Date:
December 10, 2025
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
26.45%
Purchase this report to view the information.
25%
Purchase this report to view the information.
21.82%
Purchase this report to view the information.
9.46%
Purchase this report to view the information.
8.99%
Company Performance
Financial values in the chart are available after Drogueria Inti S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BOB. Absolute financial data is included in the purchased report.
Net sales revenue
17.89%
Total operating revenue
17.89%
Operating profit (EBIT)
109.28%
EBITDA
181.98%
Net Profit (Loss) for the Period
-2.04%
Total assets
-4.02%
Total equity
-15.51%
Operating Profit Margin (ROS)
8.7%
Net Profit Margin
-1.12%
Return on Equity (ROE)
0.99%
Debt to Equity Ratio
31.66%
Quick Ratio
-0.65%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?